Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LOC387715/HTRA1 variants and the response to combined photodynamic therapy with intravitreal bevacizumab for polypoidal choroidal vasculopathy.

Retina (Philadelphia, Pa.) - 1 Feb 2012

Park Dong Ho, Kim In Taek

Abstract excerpt

PURPOSE: To investigate whether there was an association with the LOC387715/HTRA1 variants and a response to combined photodynamic therapy with intravitreal bevacizumab for polypoidal choroidal vasculopathy. METHODS: Combined photodynamic therapy with intravitreal bevacizumab was repeated every 3 months until the disappearance of angiographic signs in the active lesions of 51 eyes with polypoidal choroidal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Peripheral Vascular Diseases
Share to Angiogenesis Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bevacizumab

Share to Choroid Diseases

Share to High-Temperature Requirement A Serine Peptidase 1

Share to Intravitreal Injections

Share to Photochemotherapy

Share to Polyps

Source

Identifiers

PMID: 21817962
DOI: 10.1097/IAE.0b013e318225290f

Genes

HTRA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LOC387715/HTRA1 variants and the response to combined photodynamic therapy with intravitreal bevacizumab for polypoidal choroidal vasculopathy.PMID 21817962Read ↗

LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population.Semantic proximity Read ↗

Association of LOC387715 A69S genotype with visual prognosis after photodynamic therapy for polypoidal choroidal vasculopathy.Semantic proximity Read ↗

Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population.Semantic proximity Read ↗

Pharmacogenetic associations with long-term response to anti-vascular endothelial growth factor treatment in neovascular AMD patients.Semantic proximity Read ↗

HTRA1 promoter variant differentiates polypoidal choroidal vasculopathy from exudative age-related macular degeneration.Semantic proximity Read ↗

Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis.Semantic proximity Read ↗

The association of polypoidal choroidal vasculopathy clinical phenotypes with previously reported genetic markers.Semantic proximity Read ↗

Genetic Risk Factors for Radiation Vasculopathy.Semantic proximity Read ↗

Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.Semantic proximity Read ↗

Association of ARMS2/HTRA1 variants with polypoidal choroidal vasculopathy phenotype in a Korean population.Semantic proximity Read ↗

LOC387715/HTRA1 polymorphisms, smoking and combined effects on exudative age-related macular degeneration in a Korean population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.